ScandiBio Therapeutics

info@scandibio.com
  • About Us
    • Our Science
    • Scientific rationale
    • The Team
  • Clinical Studies
    • Phase I/II: SERINE
    • Phase I: METABOLIC COFACTORS
    • Phase II: NAFLD
    • Phase II: AD/PD
    • Phase II: COVID-19
    • Phase III: COVID-19
  • Publications
  • News
  • Contact

Monthly Archives: April 2020

ScandiBio Therapeutics   →  2020   →  April
27
Apr
Date April 27, 2020
Categories News

The results of a phase I study of CMCS have been published

The results of a Phase I study have been published in the journal Molecular Systems Biology describing the kinetics of the Combine...
Read More
Author SCANDIBIO

Categories

  • News 16

Recent Posts

  • Metabolic Activators Therapy Improve Liver Fat in NAFLD PatientsOctober 25, 2021
  • Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Parkinson’s disease patientsAugust 5, 2021
  • Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Alzheimer’s disease patientsJuly 20, 2021
  • The results of a phase II and III clinical trials about the treatment of COVID-19 patients with CMAs have been published at Advanced ScienceJune 29, 2021
  • Phase 3 human clinical trial shows that metabolic activators accelerates recovery in COVID-19 patientsFebruary 24, 2021

Archives

  • October 2021
  • August 2021
  • July 2021
  • June 2021
  • February 2021
  • October 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
Copyright © 2020 ScandiBio Therapeutics. All rights reserved.